Contact information
Email address available at https://www.ox.ac.uk/gsearch
Websites
-
Sherlock Group | Immunobiology of Systemic Rheumatic Disease
Principal Investigator, Kennedy Institute
Jonathan Sherlock
Honorary Senior Clinical Research Fellow
Key publications
-
The biology of IL-23 and IL-17 and their therapeutic targeting in rheumatic diseases
Journal article
Sherlock JP. et al, (2015), Current Opinion in Rheumatology, 27, 71 - 75
Recent publications
-
Spondyloarthropathy: interleukin 23 and disease modification.
Journal article
Sherlock JP. et al, (2015), Lancet, 385, 2017 - 2018
-
The biology of IL-23 and IL-17 and their therapeutic targeting in rheumatic diseases
Journal article
Sherlock JP. et al, (2015), Current Opinion in Rheumatology, 27, 71 - 75
-
The biology of IL-23 and IL-17 and their therapeutic targeting in rheumatic diseases.
Journal article
Sherlock JP. et al, (2015), Curr Opin Rheumatol, 27, 71 - 75
-
IL-23 in Health and Disease
Chapter
Sherlock JP. et al, (2014), Cytokine Frontiers, 179 - 198
-
The critical role of interleukin-23 in spondyloarthropathy
Journal article
Sherlock JP. et al, (2014), MOLECULAR IMMUNOLOGY, 57, 38 - 43